Rifaximin in Patients With Diabetic Gastroparesis

Summary

Researchers are trying to determine if subjects with diabetic gastroparesis and symptoms of bloating will have a greater improvement in bloating symptoms when treated with rifaximin.

Timeline

Start

2019-06-14

Primary completion

2025-04-08

Completion

2025-04-11

Outcome

Outcome not reported

Stopped (Enrollment): “Sponsor discontinued placebo. Unable to meet enrollment goals.”

Drugs

Indications